PATENT CLAIM ANALYSIS

Application Number: 15882936
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["435", "007930"]

Abstract:
The invention provides TIMP2 immunoassays with improved clinical performance, particularly when used in the evaluation of renal injuries. The immunoassays rely on the selection and use of antibodies and antibody pairs that exhibit improved assay performance when used in complex clinical specimens such as biological fluids, and particularly when used in rapid assay formats such as lateral flow test devices.

Claim (Index 9):
An isolated rabbit monoclonal antibody according to  claim 4 , wherein the kit further comprises a calibration to relate the detectable signal to a concentration of TIMP-2.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 86.0
- Lexical Diversity: 1.48837
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14910661', '15818669', '15035205', '11478972', '11614836']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5863649973617039
- 35 USC 102 Novelty (BERT): 0.5439066988901942
- Combined Prediction Score: 0.582119167514553
- Mean Citation Score: 263.107908
- Max Citation Score: 383.5628
- Similarity Product: 281.9985894739628

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test